- Home
- » Tags
- » Arformoterol
Top View
- Dual Therapy Strategies for COPD: the Scientific Rationale for LAMA + LABA
- Arformoterol: Rationale for Use in Chronic Obstructive Pulmonary Disease
- Exercise Induced Asthma Test Instructions for Patients
- Stembook 2018.Pdf
- Sunovion to Present Health Outcomes Data Supporting Brovana® (Arformoterol Tartrate) Inhalation Solution in Patients with COPD
- COPD: Inhaled Medications Drugs and Delivery 2016
- Federal Register/Vol. 84, No. 212/Friday, November 1, 2019
- Long-Acting Beta-Agonist
- Stable Chronic Obstructive Pulmonary Disease (COPD) Management Colleen Sakon, Pharmd BCPS September 27, 2018 Disclosures
- Drug/Substance Trade Name(S)
- 1 APPENDICES Appendix 1. Inhalers Included in The
- ANORO ELLIPTA (Umeclidinium and Vilanterol Inhalation Powder)
- Efficacy of a New Once-Daily Long-Acting Inhaled B2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD
- TRELEGY ELLIPTA (Fluticasone Furoate, Umeclidinium, and Vilanterol Changes Occur, Consider Appropriate Therapy
- Pharmacological Treatment Options and Tier Coverage for Copd/Asthma
- Respiratory Beta-Agonists
- Prior Authorization PDL Implementation Schedule
- COPD 2013: an Update on Treatment and Newly Approved Medications for Pharmacists Katie Campoli Meyer
- IJBCP International Journal of Basic & Clinical Pharmacology a Pharmacoepidemiological Study of Prescription Patterns Of
- Short-Term Exposure to Intermittent Hypoxia Leads to Changes in Gene
- A Stepwise Approach to Management of Stable COPD with Inhaled Pharmacotherapy: a Review
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Chronic Obstructive Pulmonary Disease (“COPD”) Medication Guide
- Drug Development for Asthma and COPD: a Regulatory Perspective
- Trelegy Ellipta (Fluticasone Furoate/Umeclidinium/Vilanterol)
- Bronchodilators
- WO 2014/007766 Al 9 January 2014 (09.01.2014) P O P C T
- Inhalation Solutions-Beta 2 Agonists, Anticholinergics, Corticosteroids
- 2018 GOLD Pocket Guide
- Long-Acting Asthma and COPD Drugs Drug Effectiveness Review Project Summary Report
- Preferred Drug List (PDL)
- MEDICATION GUIDE 15 Mcg*/2 Ml Arformoterol
- Anoro Ellipta (Umeclidinium Bromide and Vilanterol)
- Therapeutic Class Overview Β2-Agonists Single Entity Agents
- 207930Orig1s000
- WALLET CARD2021 Examples of Prohibited and Permitted Substances and Methods Effective Jan
- Cross Discipline Team Leader Review
- Health Resource Utilization for Inpatients with COPD Treated with Nebulized Arformoterol Or Nebulized Formoterol
- Literature Search Strategy for Treatment of Stable
- Compatible Stability and Aerosol Characteristics of Atrovent® (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Long-Acting Bronchodilators: Salmeterol, Formoterol, and Arformoterol
- Role of Arformoterol in the Management of COPD
- Quantity Limits — Select
- Arformoterol Tartrate (Brovana) Reference Number: CP.PMN.201 Effective Date: 09.01.18 Last Review Date: 08.20 Line of Business: HIM, Medicaid Revision Log
- 1 BROVANA 2 (Arformoterol Tartrate) Inhalation Solution 3 15 Mcg*/2 Ml
- Brovana (Arformoterol)
- Non-Preferred Drug List (NPDL)
- Role of Once-Daily Glycopyrronium Bromide (NVA237) in the Management of COPD
- Prohibited List Q&A
- Inhaled Long Acting Β2 Agonists for COPD
- Inhaled Beta-Agonists
- Chirality of Β2-Agonists. an Overview of Pharmacological Activity, Stereoselective Analysis, and Synthesis
- COPD Medications Your Doctor May Prescribe Medicine to Reduce Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
- Arformoterol
- DUAKLIR® PRESSAIR® (DU-Aakl-Ir PRESS-Air) (Aclidinium Bromide/Formoterol Fumarate) Inhalation Powder
- BROVANA Inhalation Solution Is Contraindicated in Patients with a BROVANA® Safely and Effectively
- Therapeutic Class Overview Long-Acting Inhaled Β2-Agonists (Single Entity)
- Arformoterol
- 2021 Prohibit List Summary of Major Modifications and Explanatory Notes
- Bronchodilators, Long-Acting Beta-Agonists Therapeutic Class Review
- Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone Or N-Acetylcysteine
- FDA Panel Gives Nod to MRSA Antimicrobial
- Drug Monograph Drug/Drug Class: Anoro™ Ellipta (Umeclidinium